Search Results
Results found for "Timo De Groof"
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Early In Vivo Wins the Race When is the right time to move beyond cell assays? “Target residence time in vivo correlates beautifully with activity. Modern real-time assays can deliver these insights earlier, faster, and cheaper than most teams assume Every misaligned study is not just wasted budget—it’s lost time. Program Kill vs.
- The Hidden Cost of Unclear Biotech Positioning
Over time, this constant adjustment drains confidence and momentum, even when the science is strong. Over time, founders compensate by explaining more, not realizing that explanation is a symptom, not a The most damaging effect is subtle. ✅ Founders start adapting their message in real time , trying to mid-conversation , which increases confidence and coherence Alignment can be tested quickly , saving time from founders. 👉 They no longer carry the responsibility of making every detail meaningful in real time
- How Early Strategic Decision Making Creates Alignment and Better Results
through dramatic moves or bold announcements, but through subtle direction-setting that compounds over time By the time results show up, direction has already been set. Timing shapes results. Early decisions set the direction long before outcomes appear. Over time, this friction compounds and erodes confidence, even when the underlying strategy is sound. It is something you design early, one deliberate decision at a time .
- The Hidden Cost of Ambition in Biotech Leadership
The real challenge for biotech leaders is simple and demanding at the same time: 👉 How do you stay ambitious It means structuring how that vision unfolds over time . 👉 The strongest biotech leaders understand Every expansion consumes capital, time, and leadership bandwidth. The external narrative becomes coherent. ✅ And over time, biotech fundraising becomes less about persuasion
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
staining is a technique that helps differentiate cells and has been used in flow cytometry for a long time This facilitates the study of receptor dynamics, ligand binding and signaling in real time. the advantages enumerated previously, fluorescent ligands provide new capabilities: - Real time
- Terry’s Corner, Celtarys' Leap, and the $7B GPCR Horizon
and early safety in real development contexts Advance with nuanced lessons on allostery, residence time Read how scientific need and timing drove the leap from academia to application.
- Bell-Evans model and steered molecular dynamics in uncovering the dissociation kinetics of ligands..
kinetics-based drug development have become immensely interested in predicting the drug target residence time Screening drug candidates in terms of their computationally predicted residence times, which is a measure from steered molecular dynamics simulations and the Bell-Evans model to predict the absolute residence times We have predicted the absolute ligand residence times on the timescale of seconds.
- The Real Cost of Strategic Overload in Biotech
At the same time, the team is preparing for biotech fundraising. When multiple programs advance at the same time, trade-offs become implicit instead of explicit. At the same time, boards expect growth, grants require alignment, and potential partners introduce new By the time biotech fundraising begins, investors are not only evaluating data.
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
Bioluminescence Resonance Energy Transfer (BRET), has revolutionized the study of GPCRs by enabling real-time One of the significant advantages of FRET and BRET-based sensors is their ability to provide real-time discovery efforts by enabling the precise characterization of pharmacological interventions in real time Galés, C., et al., Real-time monitoring of receptor and G-protein interactions in living cells. Eidne, Bioluminescence resonance energy transfer (BRET) for the real-time detection of protein-protein
- Understanding the Journey: Catherine Demery's Path to Addiction Science
Learning the Lab, Learning Herself During her time at the contract research organization (CRO) in Ann that would reshape her academic ambitions. “...I had a light bulb moment where I felt for the first time For the first time, she saw herself as a future researcher, not just a technician or a student.
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
Separate effect size from time: Use allosteric modulators to expand therapeutic index and reduce overdose The Advantages Live-cell imaging: visualize receptor–ligand interactions in real time, without disturbing Why It Matters In the CNS, where receptor localization and real-time signaling shape therapeutic outcomes Access this week’s full Premium Edition here ➤ What our members say "This came at just the most perfect time
- Exclusive Access: Terry's Corner is LIVE + Your Premium Member Discount!
GPCR Premium Members a significantly reduced access to Terry's Corner for a limited time.
- From GPCR Data Chaos to Decisive Action
Real-Time Global Insight As founder of Dr. Even strong science stalls without operational structure ✅ Scattered data = missed insights = wasted time
- From Ox Liver to AI: How the History of Pharmacology Shapes Its Future
Whether you're stepping into pharmacology for the first time or rekindling your interest, this lesson
- Beyond the Probe: Scaling Innovation From the Bench to Product Launch
positions, tailor activity (agonist or antagonist), and retain biological function, all while skipping the time-consuming
- Science Needs Rigor, But Also Joy
Watch Episode 166 When’s the last time you argued in the lab about injecting GTPγS?
- Why Fundraising Mistakes Kill Strong Biotech Startups
Over time, these small shifts accumulate. Roadmaps bend toward what sounds fundable instead of what creates durable value. 👉 Over time, the company Programs move forward because they sound fundable, not because the data justifies the timing. By the time founders sense that something feels off, the logic has already normalized. 👉 The company
- 📰 GPCR Weekly News, April 29 to May 5, 2024
If you aren't joining us this time, stay tuned for more Dr. GPCR University content coming soon.
- Reflections on My PhD Journey: Lessons Learned
generating data when experiments are working smoothly, but neglecting to analyze that data in real-time Procrastination may seem tempting, but tackling your work incrementally will save time and reduce stress
- How GPCR Spatial Signaling Sparked a Scientific Journey
Instead of dreading lab time, she found herself chasing questions late into the night. By understanding how signaling is organized in time and space, her team is opening doors to next-generation
- Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs
Ask your questions in real time — then revisit the material anytime. Structured continuity. Terry Kenakin (for a limited time).
- Early Safety Assays: Identifying Showstoppers in GPCR Drug Discovery Pipelines Early
Cytotoxicity is multifactorial and mechanism-dependent Early in vitro screens save time by revealing As GPCR science and pharmacological innovation accelerate, timely guidance from foundational to advanced
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
This has direct implications for: Assay timing and readout design Misclassification of lead candidates walk away with tools to: Interpret probe-dependent effects Model and anticipate longer equilibration times
- In vivo detection of GPCR-dependent signaling using fiber photometry and FRET-based biosensors
photometry with FRET-based biosensors, we were able to track GPCR-dependent signaling pathways over time weeks to allow biosensor expression, fiber photometry is used in order to record drug responses in real time
- The Hidden Burn: How Internal Misalignment Drains Your Biotech’s Runway
And by the time you catch it, your burn rate is up and your traction is down. By the time it surfaces, you’ve lost two months of budget and alignment. 2️⃣ Milestone redefinition slowly redirects energy, delays clarity, and erodes momentum. 👉 You don’t notice it until you’re out of time
- Nuclear localization of histamine receptor 2 in primary human lymphatic endothelial cells
In this study, for the first time, we demonstrate the nuclear localization of H2R in lymphatic endothelial At the same time, H2R as a GPCR imparts many unresolved questions, such as the functional relevance of
- Scientific Isolation: The Real Reason Early Biotechs Lose Traction
They chase direction, intent, and timing. In practice, founders overestimate how much time they have, usually by several months.
- From Failed Experiments to Predictive GPCR Models
While others refined lab techniques, he found himself gravitating toward structural models in his spare time It was the first time he found himself immersed in a computational environment, and he realized how much At the time, there were no solved structures of GPCRs readily available, so his work remained disconnected
- Inverse Agonists, Lymphatic Fixes & β-arrestin Tricks
It’s a simple way to share valuable resources and support the field—one connection at a time.
- How Schild Analysis Protects Your Conclusions in GPCR Research
hinges on where receptors actually are, how they internalize, and how tissues interpret signals in real time For those who prefer to contribute outside of membership, one-time or recurring donations also ensure
























